Page last updated: 2024-08-23

phorbol 12,13-dibutyrate and sildenafil citrate

phorbol 12,13-dibutyrate has been researched along with sildenafil citrate in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Inoue, H; Kikkawa, K; Mochida, H; Noto, T; Takagi, M; Yano, K	1

Other Studies

1 other study(ies) available for phorbol 12,13-dibutyrate and sildenafil citrate

Article	Year
Sildenafil and T-1032, phosphodiesterase type 5 inhibitors, showed a different vasorelaxant property in the isolated rat aorta. European journal of pharmacology, 2002, Apr-05, Volume: 440, Issue:1 Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Aorta, Thoracic; Binding, Competitive; Calcium Channels, L-Type; Calcium Chloride; Cyclic AMP; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 5; Dose-Response Relationship, Drug; Endothelium, Vascular; In Vitro Techniques; Isoquinolines; Male; NG-Nitroarginine Methyl Ester; Phorbol 12,13-Dibutyrate; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Piperazines; Purines; Pyridines; Radioligand Assay; Rats; Rats, Wistar; Sildenafil Citrate; Sulfones; Vasodilation; Vasodilator Agents	2002

Article

Year

Sildenafil and T-1032, phosphodiesterase type 5 inhibitors, showed a different vasorelaxant property in the isolated rat aorta.

European journal of pharmacology, 2002, Apr-05, Volume: 440, Issue:1

Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Aorta, Thoracic; Binding, Competitive; Calcium Channels, L-Type; Calcium Chloride; Cyclic AMP; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 5; Dose-Response Relationship, Drug; Endothelium, Vascular; In Vitro Techniques; Isoquinolines; Male; NG-Nitroarginine Methyl Ester; Phorbol 12,13-Dibutyrate; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Piperazines; Purines; Pyridines; Radioligand Assay; Rats; Rats, Wistar; Sildenafil Citrate; Sulfones; Vasodilation; Vasodilator Agents

2002